ibuprofen dr.max 20 mg/ml perorálna suspenzia
dr. max pharma s.r.o., Česká republika - ibuprofén - 07 - analgetica, antipyretica
ambroxol dr.max 30 mg/5 ml sirup
dr. max pharma s.r.o., Česká republika - ambroxol - 52 - expectorantia, mucolytica
ambroxol dr.max 15 mg/5 ml sirup
dr. max pharma s.r.o., Česká republika - ambroxol - 52 - expectorantia, mucolytica
ibuprofen dr.max 400 mg mäkké kapsuly
dr. max pharma s.r.o., Česká republika - ibuprofén - 07 - analgetica, antipyretica
ibuprofen dr.max 400 mg filmom obalené tablety
dr. max pharma s.r.o., Česká republika - ibuprofén - 29 - antirheumatica, antiphlogistica, antiuratica
ibuprofen dr. max pharma 400 mg filmom obalené tablety
dr. max pharma s.r.o., Česká republika - ibuprofén - 29 - antirheumatica, antiphlogistica, antiuratica
cetirizin dr.max 10 mg
dr. max pharma s.r.o., Česká republika - cetirizín - 24 - antihistaminica, histamin
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - drogy obštrukčnej choroby dýchacích ciest, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - drogy obštrukčnej choroby dýchacích ciest, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
paramax horúci nápoj
vitabalans oy, fínsko - paracetamol - 07 - analgetica, antipyretica